Sarah Cavanaugh

Sarah Boylan Cavanaugh is an accomplished executive with extensive experience in corporate affairs and communications. Currently serving as Senior Vice President at Celldex Therapeutics since August 2012, Sarah leads key functions such as Investor Relations, Corporate Communications, Human Resources, and Organizational Development. Prior to this role, Sarah held the position of Vice President at MacDougall Biomedical Communications, where strategic planning and communications were focal points for clients in biotechnology and life sciences. Additional experience includes directorial roles at Point Therapeutics, Fallon Community Health Plan, and the American Cancer Society, where Sarah developed comprehensive communications strategies and managed diverse teams. Sarah's academic background includes a degree from the University of New Hampshire.